Search

Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.

… Friday, April 1, 2022 Symantha Wilson knows she is one of the lucky ones. The 26-year-old Long Island resident was nearing the end of a six-month chemotherapy regimen for stage 2 Hodgkin lymphoma last June. The treatment had been very effective, wiping out most of the cancer cells. But with just over

… Job Title Chairman Attending Degree MD, PhD Email [email protected]

… Job Title Lab Head Degree PhD Email [email protected] Lab Phone 212-639-7339 Office Fax 212-794-4342 Office Phone 212-639-6814

More sugar available for immune cells could mean better immune responses against cancer.

… Monday, February 15, 2021 Summary New research from Memorial Sloan Kettering scientists suggests that a way to improve immunotherapy is by altering immune cells’ access to sugar. Cancer cells and immune cells share something in common: They both love sugar. Sugar is an important nutrient. All cells use

Like all researchers, nurse scientists design studies, accumulate data, and publish their findings. Their concentration in nursing means that they’re focused on patient needs, perspectives, and outcomes. Whereas a medical doctor might study how a drug is working, a nurse scientist may take a more holistic view of how a treatment affects a patient’s and their family’s quality of life.

… Friday, January 13, 2023 The mission for Kristen Fessele, PhD, RN, ANP-BC, AOCN, is personal. Her mother had survived cancer. But Dr. Fessele, a nurse scientist at Memorial Sloan Kettering Cancer Center (MSK), wanted to see her more than just survive — she wanted to see her thrive again. Dr. Fessele

… Job Title Research Fellow Elizabeth received her BS in Biology from Boston College and her PhD in Cellular and Molecular Biology from the University of Michigan. Currently, she is working to understand the contribution of the pioneering factor FOXA1 on prostate cancer pathogenesis. Education University

… SK2018-105, SK2020-043, SK2021-100 SUMMARY OF INVENTION Certain surgeries pose a high risk of unintentional nerve injury and can result in serious adverse events including loss of function of the limbs/organs, pain, and/or muscle paralysis. Indeed, prevention of nerve damage during oncologic surgeries

… Job Title Senior Research Scientist Email [email protected] Office Fax 646-422-0197 Office Phone 646-888-2528

Researchers MSK and their collaborators at Mount Sinai have developed an artificial intelligence-based model to predict who will benefit from immune checkpoint inhibitors using only routine blood tests and clinical data.

… Monday, January 6, 2025 Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors — a type of immunotherapy — using only routine blood tests and clinical data. The artificial intelligence–based

Explore how we use chemotherapy and targeted therapy to treat cancer that has spread beyond the kidney.

… We use different treatments if the kidney cancer has spread through the blood and started new growth in other places. Your care team will talk with you about options for systemic therapy, such as immunotherapy or targeted kidney cancer treatments. Systemic therapy is when medicine is given intravenously